Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · IEX Real-Time Price · USD

2.620

-0.140 (-5.07%)

At close: Jul 2, 2024, 4:00 PM

2.750

+0.130 (4.96%)

After-hours: Jul 2, 2024, 7:33 PM EDT

Lexaria Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Year	2023	2022	2021	2020	2019	2018 - 2005
Net Income	-6.66	-7.27	-4.03	-3.93	-4.1	Upgrade
Depreciation & Amortization	0.19	0.15	0.16	0.16	0.06	Upgrade
Share-Based Compensation	0.17	0.75	0.41	1.14	0.63	Upgrade
Other Operating Activities	0.47	1.61	-0.37	0.17	0.47	Upgrade
Operating Cash Flow	-5.88	-4.88	-3.99	-2.62	-3.01	Upgrade
Capital Expenditures	-0.03	-0.05	0	0	-0.65	Upgrade
Acquisitions	0	0	0.27	0	0	Upgrade
Change in Investments	0	0	0	0.01	0	Upgrade
Other Investing Activities	-0.14	-0.13	-0.08	-0.03	-0.12	Upgrade
Investing Cash Flow	-0.17	-0.18	0.19	-0.03	-0.77	Upgrade
Share Issuance / Repurchase	1.59	0	13.49	2.67	2.33	Upgrade
Debt Issued / Paid	0	-0.04	-0.07	-0.01	0	Upgrade
Other Financing Activities	-	-	-	-	1	Upgrade
Financing Cash Flow	1.59	-0.04	13.42	2.65	3.33	Upgrade
Net Cash Flow	-4.46	-5.1	9.62	0.01	-0.44	Upgrade
Free Cash Flow	-5.91	-4.93	-3.99	-2.62	-3.65	Upgrade
Free Cash Flow Margin	-2614.84%	-1929.75%	-552.02%	-831.91%	-1640.42%	Upgrade
Free Cash Flow Per Share	-0.89	-0.84	-0.91	-0.94	-1.41	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).